Endonovo Therapeutics Inc (ENDV)

[Stiggie]

You should read the September 26th PR again.

The Company is currently preparing to conduct additional pre-clinical studies using its newly developed electroceutical technology in the treatment of critical limb ischemia, kidney disease and Non-Alcoholic Steatohepatitis (NASH).

Previous PR's indeed mentioned that they were commencing the trials, but as you can see in their last update they haven't even started.

It will not take as long as the heart study since they were still figuring out the most effective signal, hence the big delay. But I think it will only be somewhere in December (2nd half).